Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

"Spot Sign" Selection of Intracerebral Hemorrhage to Guide Hemostatic Therapy: SPOTLIGHT

NCT01359202 is registered in ClinicalTrials.gov with Dr. David Gladstone as lead sponsor.

NCT NCT01359202
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01359202 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
"Spot Sign" Selection of Intracerebral Hemorrhage to Guide Hemostatic Therapy: SPOTLIGHT
Lead sponsor
Dr. David Gladstone
Phase
Phase 2
Overall status
Completed
Start date
May 31, 2011
Completion date
October 3, 2018
Enrollment
50 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

stroke